MeadowBrook Investment Advisors LLC Makes New $324,000 Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

MeadowBrook Investment Advisors LLC acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) in the 4th quarter, Holdings Channel reports. The fund acquired 10,130 shares of the company’s stock, valued at approximately $324,000.

Several other institutional investors and hedge funds have also made changes to their positions in SGRY. DekaBank Deutsche Girozentrale acquired a new position in shares of Surgery Partners in the 3rd quarter valued at about $39,000. Strs Ohio purchased a new stake in shares of Surgery Partners during the 4th quarter valued at approximately $51,000. Signaturefd LLC acquired a new stake in shares of Surgery Partners during the 3rd quarter worth about $56,000. Nisa Investment Advisors LLC boosted its position in shares of Surgery Partners by 69.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company’s stock worth $86,000 after purchasing an additional 1,210 shares during the period. Finally, Headlands Technologies LLC purchased a new position in Surgery Partners in the 4th quarter valued at approximately $145,000.

Insider Buying and Selling at Surgery Partners

In related news, CEO Jason Eric Evans sold 5,780 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $35.08, for a total transaction of $202,762.40. Following the sale, the chief executive officer now directly owns 419,118 shares in the company, valued at approximately $14,702,659.44. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Surgery Partners news, insider Bradley R. Owens sold 1,040 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $35.22, for a total transaction of $36,628.80. Following the completion of the transaction, the insider now directly owns 73,149 shares of the company’s stock, valued at approximately $2,576,307.78. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jason Eric Evans sold 5,780 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $35.08, for a total value of $202,762.40. Following the completion of the sale, the chief executive officer now directly owns 419,118 shares of the company’s stock, valued at $14,702,659.44. The disclosure for this sale can be found here. Insiders have sold a total of 14,664 shares of company stock valued at $477,225 over the last ninety days. Corporate insiders own 2.60% of the company’s stock.

Wall Street Analyst Weigh In

SGRY has been the subject of several analyst reports. Benchmark reiterated a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a report on Wednesday, May 1st. Barclays began coverage on Surgery Partners in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 target price on the stock. Citigroup dropped their target price on Surgery Partners from $43.00 to $42.00 and set a “buy” rating on the stock in a research report on Tuesday, February 27th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a report on Thursday, February 29th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Wednesday, April 10th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $43.63.

Surgery Partners Trading Up 10.7 %

Shares of NASDAQ:SGRY traded up $2.75 during midday trading on Tuesday, reaching $28.35. The company’s stock had a trading volume of 1,628,556 shares, compared to its average volume of 906,676. The business has a 50 day moving average price of $27.54 and a 200 day moving average price of $29.79. Surgery Partners, Inc. has a 1 year low of $22.05 and a 1 year high of $45.79. The firm has a market cap of $3.60 billion, a price-to-earnings ratio of -280.70, a price-to-earnings-growth ratio of 2.24 and a beta of 2.75. The company has a quick ratio of 1.57, a current ratio of 1.71 and a debt-to-equity ratio of 0.89.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, February 26th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. Surgery Partners had a positive return on equity of 3.65% and a negative net margin of 0.43%. The business had revenue of $735.40 million during the quarter, compared to the consensus estimate of $741.93 million. During the same period in the prior year, the firm posted $0.22 EPS. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. Research analysts forecast that Surgery Partners, Inc. will post 0.78 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.